[Other forms of immunomodulation in allergic patients]. 2000

I Cortegano, and V Del Pozo, and M Rojo, and B Cárdaba, and E Aceituno, and S Gallardo, and A Mínguez, and I Arrieta, and P Palomino, and C Lahoz
Servicio de Inmunología, Fundación Jiménez Díaz, Madrid, España.

UI MeSH Term Description Entries
D006967 Hypersensitivity Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. Allergy,Allergic Reaction,Allergic Reactions,Allergies,Hypersensitivities,Reaction, Allergic,Reactions, Allergic
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D003888 Desensitization, Immunologic Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity. Allergen Immunotherapy,Allergy Shots,Hyposensitization Therapy,Immunotherapy, Allergen,Venom Immunotherapy,Immunologic Desensitization,Therapy, Hyposensitization,Allergen Immunotherapies,Allergy Shot,Desensitizations, Immunologic,Hyposensitization Therapies,Immunologic Desensitizations,Immunotherapy, Venom,Shot, Allergy,Venom Immunotherapies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000485 Allergens Antigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). Allergen
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000943 Antigens, Differentiation Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation. Differentiation Antigen,Differentiation Antigens,Differentiation Antigens, Hairy Cell Leukemia,Differentiation Marker,Differentiation Markers,Leu Antigen,Leu Antigens,Marker Antigen,Marker Antigens,Markers, Differentiation,Antigen, Differentiation,Antigen, Leu,Antigen, Marker,Antigens, Leu,Antigens, Marker,Marker, Differentiation
D012697 Serine Endopeptidases Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis. Serine Endopeptidase,Endopeptidase, Serine,Endopeptidases, Serine

Related Publications

I Cortegano, and V Del Pozo, and M Rojo, and B Cárdaba, and E Aceituno, and S Gallardo, and A Mínguez, and I Arrieta, and P Palomino, and C Lahoz
October 1983, Der Internist,
I Cortegano, and V Del Pozo, and M Rojo, and B Cárdaba, and E Aceituno, and S Gallardo, and A Mínguez, and I Arrieta, and P Palomino, and C Lahoz
April 2005, The Netherlands journal of medicine,
I Cortegano, and V Del Pozo, and M Rojo, and B Cárdaba, and E Aceituno, and S Gallardo, and A Mínguez, and I Arrieta, and P Palomino, and C Lahoz
January 2009, Annual review of medicine,
I Cortegano, and V Del Pozo, and M Rojo, and B Cárdaba, and E Aceituno, and S Gallardo, and A Mínguez, and I Arrieta, and P Palomino, and C Lahoz
January 1993, Israel journal of medical sciences,
I Cortegano, and V Del Pozo, and M Rojo, and B Cárdaba, and E Aceituno, and S Gallardo, and A Mínguez, and I Arrieta, and P Palomino, and C Lahoz
February 1988, Transplantation proceedings,
I Cortegano, and V Del Pozo, and M Rojo, and B Cárdaba, and E Aceituno, and S Gallardo, and A Mínguez, and I Arrieta, and P Palomino, and C Lahoz
December 1984, Neurology,
I Cortegano, and V Del Pozo, and M Rojo, and B Cárdaba, and E Aceituno, and S Gallardo, and A Mínguez, and I Arrieta, and P Palomino, and C Lahoz
June 2003, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology,
I Cortegano, and V Del Pozo, and M Rojo, and B Cárdaba, and E Aceituno, and S Gallardo, and A Mínguez, and I Arrieta, and P Palomino, and C Lahoz
June 2020, Trends in cancer,
I Cortegano, and V Del Pozo, and M Rojo, and B Cárdaba, and E Aceituno, and S Gallardo, and A Mínguez, and I Arrieta, and P Palomino, and C Lahoz
May 2013, American journal of rhinology & allergy,
I Cortegano, and V Del Pozo, and M Rojo, and B Cárdaba, and E Aceituno, and S Gallardo, and A Mínguez, and I Arrieta, and P Palomino, and C Lahoz
January 2013, American journal of rhinology & allergy,
Copied contents to your clipboard!